JP2019535671A5 - - Google Patents

Download PDF

Info

Publication number
JP2019535671A5
JP2019535671A5 JP2019521064A JP2019521064A JP2019535671A5 JP 2019535671 A5 JP2019535671 A5 JP 2019535671A5 JP 2019521064 A JP2019521064 A JP 2019521064A JP 2019521064 A JP2019521064 A JP 2019521064A JP 2019535671 A5 JP2019535671 A5 JP 2019535671A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
polymer
cyclopropylmethoxy
methylsulfonylphenyl
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019521064A
Other languages
English (en)
Japanese (ja)
Other versions
JP7129973B2 (ja
JP2019535671A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/057439 external-priority patent/WO2018075796A1/en
Publication of JP2019535671A publication Critical patent/JP2019535671A/ja
Publication of JP2019535671A5 publication Critical patent/JP2019535671A5/ja
Priority to JP2022066855A priority Critical patent/JP2022095897A/ja
Application granted granted Critical
Publication of JP7129973B2 publication Critical patent/JP7129973B2/ja
Priority to JP2024021416A priority patent/JP2024056905A/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019521064A 2016-10-20 2017-10-19 ブロモドメイン阻害剤 Expired - Fee Related JP7129973B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022066855A JP2022095897A (ja) 2016-10-20 2022-04-14 ブロモドメイン阻害剤
JP2024021416A JP2024056905A (ja) 2016-10-20 2024-02-15 ブロモドメイン阻害剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662410756P 2016-10-20 2016-10-20
US62/410,756 2016-10-20
PCT/US2017/057439 WO2018075796A1 (en) 2016-10-20 2017-10-19 Bromodomain inhibitor

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022066855A Division JP2022095897A (ja) 2016-10-20 2022-04-14 ブロモドメイン阻害剤

Publications (3)

Publication Number Publication Date
JP2019535671A JP2019535671A (ja) 2019-12-12
JP2019535671A5 true JP2019535671A5 (enExample) 2020-10-22
JP7129973B2 JP7129973B2 (ja) 2022-09-02

Family

ID=62019669

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019521064A Expired - Fee Related JP7129973B2 (ja) 2016-10-20 2017-10-19 ブロモドメイン阻害剤
JP2022066855A Ceased JP2022095897A (ja) 2016-10-20 2022-04-14 ブロモドメイン阻害剤
JP2024021416A Pending JP2024056905A (ja) 2016-10-20 2024-02-15 ブロモドメイン阻害剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022066855A Ceased JP2022095897A (ja) 2016-10-20 2022-04-14 ブロモドメイン阻害剤
JP2024021416A Pending JP2024056905A (ja) 2016-10-20 2024-02-15 ブロモドメイン阻害剤

Country Status (7)

Country Link
EP (1) EP3528810A4 (enExample)
JP (3) JP7129973B2 (enExample)
CN (1) CN110099685A (enExample)
AR (1) AR109859A1 (enExample)
AU (1) AU2017345468B2 (enExample)
TW (1) TW201821062A (enExample)
WO (1) WO2018075796A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10702517B2 (en) 2015-04-22 2020-07-07 Celgene Quanticel Research, Inc. Bromodomain inhibitor
TW201642860A (zh) * 2015-04-22 2016-12-16 塞爾基因定量細胞研究公司 布羅莫結構域抑制劑
AU2019309693B2 (en) * 2018-07-23 2023-03-16 Celgene Quanticel Research, Inc. Process for the preparation of bromodomain inhibitor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL150524A0 (en) * 2000-01-07 2003-02-12 Transform Pharmaceuticals Inc High-throughput formation, identification, and analysis of diverse solid-forms
GB0919434D0 (en) * 2009-11-05 2009-12-23 Glaxosmithkline Llc Novel compounds
CN105899212A (zh) * 2013-08-06 2016-08-24 翁科埃斯克斯有限公司 利用β溴结构域抑制剂治疗弥漫性大B细胞淋巴瘤(DLBCL)的方法
US9884806B2 (en) * 2013-08-30 2018-02-06 Icahn School Of Medicine At Mount Sinai Cyclic vinylogous amides as bromodomain inhibitors
EP3290407B1 (en) * 2013-10-18 2020-01-01 Celgene Quanticel Research, Inc Bromodomain inhibitors
JP2016538310A (ja) * 2013-11-27 2016-12-08 オンコエシックス ゲーエムベーハー チエノトリアゾロジアゼピン化合物を含む医薬製剤を用いる白血病の治療方法
TW201642860A (zh) * 2015-04-22 2016-12-16 塞爾基因定量細胞研究公司 布羅莫結構域抑制劑
CN105732624B (zh) * 2016-01-28 2019-08-02 中国药科大学 吡咯[4,3,2-de]喹啉-2(1H)-酮类BRD4蛋白抑制剂的制备方法及其用途

Similar Documents

Publication Publication Date Title
JP6559719B2 (ja) (s)−6−((1−アセチルピペリジン−4−イル)アミノ)−n−(3−(3、4−ジヒドロイソキノリン−2(1h)−イル)−2−ヒドロキシプロピル)ピリミジン−4−カルボキサミドの結晶塩
WO2013066833A1 (en) Compounds and methods to inhibit histone deacetylase (hdac) enzymes
CN114222743A (zh) 氧代六元环并嘧啶类化合物,其制法与医药上的用途
JP2011057693A5 (enExample)
JP2018513863A5 (enExample)
JP2015533176A5 (enExample)
JP2014511892A5 (enExample)
JP2016515561A5 (enExample)
JP2016074736A5 (enExample)
JP2015500331A5 (enExample)
JP2012510458A5 (enExample)
JP2013500314A5 (enExample)
JP2014523445A5 (enExample)
WO2019035914A8 (en) Macrocyclic mcl-1 inhibitors and methods of use
JP2017519027A5 (enExample)
JP2018503649A5 (enExample)
JP2018513863A (ja) ブロモドメイン阻害剤
RU2017134709A (ru) П-толуолсульфонат для ингибитора мек-киназы и его кристаллическая форма, и способ его получения
JP6293315B2 (ja) アリサルタン・イソプロキシル固体分散体及び該固体分散体を含有する医薬組成物
JP2024056905A (ja) ブロモドメイン阻害剤
JP2019500379A5 (enExample)
CN109311893A (zh) 含有取代环戊基的吡咯并嘧啶化合物
JP2020500907A5 (enExample)
JP2019529553A5 (enExample)
WO2019144759A1 (zh) 靶向cdk4/6激酶抑制剂的晶型